ePROs in the follow-up of cancer patients treated with immune checkpoint inhibitors: a retrospective study.
Sanna IivanainenTuomo AlankoKatriina PeltolaTeemu KonkolaJussi EkströmHenri VirtanenJussi Pekka KoivunenPublished in: Journal of cancer research and clinical oncology (2019)
The results of the current study suggest that real-world symptom data collected through the ePRO application on cancer patients receiving ICI therapy aligns with the data from clinical trials. Correlations between different symptoms occur, which might reflect therapeutic efficiency, side effects, or tumor progression. These correlations should be further investigated with data coupled to clinical outcomes.
Keyphrases
- electronic health record
- papillary thyroid
- clinical trial
- big data
- squamous cell
- randomized controlled trial
- stem cells
- data analysis
- physical activity
- young adults
- mesenchymal stem cells
- depressive symptoms
- sleep quality
- artificial intelligence
- bone marrow
- atomic force microscopy
- open label
- cell therapy
- patient reported